rs55716270
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_014844.5(TECPR2):c.952-5G>A variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0085 ( 0 hom., cov: 0)
Exomes 𝑓: 0.0057 ( 30 hom. )
Consequence
TECPR2
NM_014844.5 splice_region, splice_polypyrimidine_tract, intron
NM_014844.5 splice_region, splice_polypyrimidine_tract, intron
Scores
2
Splicing: ADA: 0.00004091
2
Clinical Significance
Conservation
PhyloP100: -0.377
Genes affected
TECPR2 (HGNC:19957): (tectonin beta-propeller repeat containing 2) The protein encoded by this gene is a member of the tectonin beta-propeller repeat-containing (TECPR) family, and contains both TECPR and tryptophan-aspartic acid repeat (WD repeat) domains. This gene has been implicated in autophagy, as reduced expression levels of this gene have been associated with impaired autophagy. Recessive mutations in this gene have been associated with a hereditary form of spastic paraparesis (HSP). HSP is characterized by progressive spasticity and paralysis of the legs. There is also some evidence linking mutations in this gene with birdshot chorioretinopathy (BSCR), which results in inflammation of the choroid and retina. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 14-102428245-G-A is Benign according to our data. Variant chr14-102428245-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 240925.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-102428245-G-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00848 (226/26640) while in subpopulation NFE AF= 0.0136 (173/12714). AF 95% confidence interval is 0.012. There are 0 homozygotes in gnomad4. There are 102 alleles in male gnomad4 subpopulation. Median coverage is 0. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 30 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TECPR2 | NM_014844.5 | c.952-5G>A | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000359520.12 | NP_055659.2 | |||
TECPR2 | NM_001172631.3 | c.952-5G>A | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | NP_001166102.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TECPR2 | ENST00000359520.12 | c.952-5G>A | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_014844.5 | ENSP00000352510 | P1 | |||
TECPR2 | ENST00000558678.1 | c.952-5G>A | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | ENSP00000453671 |
Frequencies
GnomAD3 genomes AF: 0.00849 AC: 226AN: 26624Hom.: 0 Cov.: 0
GnomAD3 genomes
AF:
AC:
226
AN:
26624
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00348 AC: 76AN: 21844Hom.: 3 AF XY: 0.00400 AC XY: 48AN XY: 11990
GnomAD3 exomes
AF:
AC:
76
AN:
21844
Hom.:
AF XY:
AC XY:
48
AN XY:
11990
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00566 AC: 3204AN: 565598Hom.: 30 Cov.: 17 AF XY: 0.00541 AC XY: 1489AN XY: 275256
GnomAD4 exome
AF:
AC:
3204
AN:
565598
Hom.:
Cov.:
17
AF XY:
AC XY:
1489
AN XY:
275256
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00848 AC: 226AN: 26640Hom.: 0 Cov.: 0 AF XY: 0.00797 AC XY: 102AN XY: 12790
GnomAD4 genome
AF:
AC:
226
AN:
26640
Hom.:
Cov.:
0
AF XY:
AC XY:
102
AN XY:
12790
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Dec 01, 2023 | TECPR2: BP4, BS2 - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 14, 2020 | - - |
Hereditary spastic paraplegia Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Aug 16, 2021 | - - |
TECPR2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 12, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Hereditary spastic paraplegia 49 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at